# The Magnetic Resonance Imaging Evaluation of Doxorubicin Cardiotoxicity

> **NCT00530101** · PHASE1 · COMPLETED · sponsor: **University of Miami** · enrollment: 3 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Doxorubicin

## Key facts

- **NCT ID:** NCT00530101
- **Lead sponsor:** University of Miami
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-07
- **Primary completion:** 2008-03
- **Final completion:** 2008-03
- **Target enrollment:** 3 (ACTUAL)
- **Last updated:** 2008-06-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00530101

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00530101, "The Magnetic Resonance Imaging Evaluation of Doxorubicin Cardiotoxicity". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT00530101. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*